ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Bayer has acquired an exclusive license to produce 10 varieties of gene-edited mustard greens developed by the US start-up Pairwise. The US firm has been “dialing down the wasabi-like flavor” of the mustard leaves by editing plant genes with CRISPR. In a separate move, Bayer and South Korea’s G+FLAS Life Sciences are codeveloping genome-edited tomatoes enhanced with vitamin D3. The collaboration leverages G+FLAS’s genome-editing technology and Bayer’s tomato germplasm.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X